» Articles » PMID: 35846773

Offense and Defense in Granulomatous Inflammation Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Granulomatous inflammation (GI) diseases are a group of chronic inflammation disorders characterized by focal collections of multinucleated giant cells, epithelioid cells and macrophages, with or without necrosis. GI diseases are closely related to microbes, especially virulent intracellular bacterial infections are important factors in the progression of these diseases. They employ a range of strategies to survive the stresses imposed upon them and persist in host cells, becoming the initiator of the fighting. Microbe-host communication is essential to maintain functions of a healthy host, so defense capacity of hosts is another influence factor, which is thought to combine to determine the result of the fighting. With the development of gene research technology, many human genetic loci were identified to be involved in GI diseases susceptibility, providing more insights into and knowledge about GI diseases. The current review aims to provide an update on the most recent progress in the identification and characterization of bacteria in GI diseases in a variety of organ systems and clinical conditions, and examine the invasion and escape mechanisms of pathogens that have been demonstrated in previous studies, we also review the existing data on the predictive factors of the host, mainly on genetic findings. These strategies may improve our understanding of the mechanisms underlying GI diseases, and open new avenues for the study of the associated conditions in the future.

Citing Articles

ZNFX1 promotes AMPK-mediated autophagy against Mycobacterium tuberculosis by stabilizing Prkaa2 mRNA.

Liu H, Han Z, Chen L, Zhang J, Zhang Z, Chen Y JCI Insight. 2023; 9(1).

PMID: 38016036 PMC: 10906457. DOI: 10.1172/jci.insight.171850.


Granulomatous inflammation in inborn errors of immunity.

Sacco K, Gazzin A, Notarangelo L, Delmonte O Front Pediatr. 2023; 11:1110115.

PMID: 36891233 PMC: 9986611. DOI: 10.3389/fped.2023.1110115.


The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis.

Yao L, Chen S, Sha W, Gu Y BMC Infect Dis. 2023; 23(1):107.

PMID: 36814228 PMC: 9945607. DOI: 10.1186/s12879-023-08073-7.


Difference between the blood samples of patients with bone and joint tuberculosis and patients with tuberculosis studied using machine learning.

Ye Z, Zhu J, Liu C, Lu Q, Wu S, Zhou C Front Surg. 2023; 9:1031105.

PMID: 36684125 PMC: 9852526. DOI: 10.3389/fsurg.2022.1031105.

References
1.
Mwipatayi B, Jeffery P, Beningfield S, Matley P, Naidoo N, Kalla A . Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005; 75(3):110-7. DOI: 10.1111/j.1445-2197.2005.03312.x. View

2.
Kim K, An D, Song J, Yoon J, Kim H, Yoon H . Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A. 2012; 109(20):7729-34. PMC: 3356628. DOI: 10.1073/pnas.1120251109. View

3.
Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold H . Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol. 2008; 9(10):1189-97. PMC: 5351782. DOI: 10.1038/ni.1654. View

4.
Geluk A, Ottenhoff T . HLA and leprosy in the pre and postgenomic eras. Hum Immunol. 2006; 67(6):439-45. DOI: 10.1016/j.humimm.2006.03.009. View

5.
Friswell M, Campbell B, Rhodes J . The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver. 2010; 4(3):295-306. PMC: 2956340. DOI: 10.5009/gnl.2010.4.3.295. View